ISA Pharmaceuticals and Regeneron Announce Strategic Immuno-Oncology Collaboration
Go back to ISA Pharmaceuticals and Regeneron Announce Strategic Immuno-Oncology Collaboration| Regeneron (NASDAQ: REGN) | Delayed: 801.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $801.82 | 52 Week High | $592.36 | |||
| Open | $801.82 | 52 Week Low | $325.35 | |||
| Day High | $801.82 | P/E | 210.45 | |||
| Day Low | $801.82 | EPS | $3.81 | |||
| Volume | 150 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 801.82 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $801.82 | 52 Week High | $592.36 | |||
| Open | $801.82 | 52 Week Low | $325.35 | |||
| Day High | $801.82 | P/E | 210.45 | |||
| Day Low | $801.82 | EPS | $3.81 | |||
| Volume | 150 | |||||

